SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-20-000061
Filing Date
2020-10-29
Accepted
2020-10-29 16:03:30
Documents
47
Period of Report
2020-10-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axon-20201029.htm   iXBRL 8-K 48835
2 EX-99.1 axgtex-991102920.htm EX-99.1 17334
3 EX-99.2 axgt8kex992102920.htm EX-99.2 61959
9 GRAPHIC axgt1.jpg GRAPHIC 5771
10 GRAPHIC axgt8kex992102920001.jpg GRAPHIC 111057
11 GRAPHIC axgt8kex992102920002.jpg GRAPHIC 266614
12 GRAPHIC axgt8kex992102920003.jpg GRAPHIC 94828
13 GRAPHIC axgt8kex992102920004.jpg GRAPHIC 105691
14 GRAPHIC axgt8kex992102920005.jpg GRAPHIC 99302
15 GRAPHIC axgt8kex992102920006.jpg GRAPHIC 109614
16 GRAPHIC axgt8kex992102920007.jpg GRAPHIC 102800
17 GRAPHIC axgt8kex992102920008.jpg GRAPHIC 77888
18 GRAPHIC axgt8kex992102920009.jpg GRAPHIC 129946
19 GRAPHIC axgt8kex992102920010.jpg GRAPHIC 113473
20 GRAPHIC axgt8kex992102920011.jpg GRAPHIC 89798
21 GRAPHIC axgt8kex992102920012.jpg GRAPHIC 110169
22 GRAPHIC axgt8kex992102920013.jpg GRAPHIC 108956
23 GRAPHIC axgt8kex992102920014.jpg GRAPHIC 86235
24 GRAPHIC axgt8kex992102920015.jpg GRAPHIC 104795
25 GRAPHIC axgt8kex992102920016.jpg GRAPHIC 78507
26 GRAPHIC axgt8kex992102920017.jpg GRAPHIC 80056
27 GRAPHIC axgt8kex992102920018.jpg GRAPHIC 99836
28 GRAPHIC axgt8kex992102920019.jpg GRAPHIC 84442
29 GRAPHIC axgt8kex992102920020.jpg GRAPHIC 135947
30 GRAPHIC axgt8kex992102920021.jpg GRAPHIC 108636
31 GRAPHIC axgt8kex992102920022.jpg GRAPHIC 93092
32 GRAPHIC axgt8kex992102920023.jpg GRAPHIC 74153
33 GRAPHIC axgt8kex992102920024.jpg GRAPHIC 77594
34 GRAPHIC axgt8kex992102920025.jpg GRAPHIC 94882
35 GRAPHIC axgt8kex992102920026.jpg GRAPHIC 107362
36 GRAPHIC axgt8kex992102920027.jpg GRAPHIC 109461
37 GRAPHIC axgt8kex992102920028.jpg GRAPHIC 110868
38 GRAPHIC axgt8kex992102920029.jpg GRAPHIC 115551
39 GRAPHIC axgt8kex992102920030.jpg GRAPHIC 127136
  Complete submission text file 0001636050-20-000061.txt   4735084

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20201029.xsd EX-101.SCH 2421
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20201029_cal.xml EX-101.CAL 712
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20201029_def.xml EX-101.DEF 1649
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20201029_lab.xml EX-101.LAB 27110
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20201029_pre.xml EX-101.PRE 14217
40 EXTRACTED XBRL INSTANCE DOCUMENT axon-20201029_htm.xml XML 12633
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 201272607
SIC: 2834 Pharmaceutical Preparations